FBLG (STOCKS)

    FibroBiologics, Inc. Common Stock

    $0.895100
    -0.035900 (-3.86%)
    Prev close: $0.931000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Biotechnology
    CEO
    Peter O'Heeron
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $4.65M
    Employees
    13
    P/E (TTM)
    -0.12
    P/B (TTM)
    1.26
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State

    Analyst Recommendations
    2
    Strong Buy
    4
    Buy
    2
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Mar 2026 (Q1)
    $-1.33 $-1.33 -0.0006 -0.05%
    Dec 2025 (Q4)
    $-0.60 $-1.79 +1.1850 +66.39%
    Sep 2025 (Q3)
    $-2.60 $-2.19 -0.4070 -18.56%
    Jun 2025 (Q2)
    $-2.40 $-2.30 -0.1050 -4.58%
    Financial Statements
    TTM (Dec 2025)
    Revenues $0.00
    Nonoperating Income/Loss -$2.00M
    Operating Expenses $16.65M
    Research and Development $7.41M
    Other Operating Expenses $9.24M
    Operating Income/Loss -$16.65M
    Income/Loss From Continuing Operations After Tax -$18.65M
    Income/Loss From Continuing Operations Before Tax -$18.65M
    Income Tax Expense/Benefit $0.00
    Net Income/Loss -$18.65M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$18.65M
    Net Income/Loss Available To Common Stockholders, Basic -$18.65M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Basic Earnings Per Share -$0.42
    Diluted Earnings Per Share -$0.42
    Basic Average Shares 44,660,518
    Diluted Average Shares 44,660,518
    Assets $9.62M
    Current Assets $6.35M
    Prepaid Expenses $1.46M
    Other Current Assets $4.89M
    Noncurrent Assets $3.27M
    Fixed Assets $842.00K
    Other Non-current Assets $2.43M
    Liabilities $3.46M
    Current Liabilities $1.76M
    Noncurrent Liabilities $1.70M
    Equity $6.16M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $6.16M
    Liabilities And Equity $9.62M
    Net Cash Flow From Operating Activities -$16.39M
    Net Cash Flow From Operating Activities, Continuing -$16.39M
    Net Cash Flow From Investing Activities -$262.00K
    Net Cash Flow From Investing Activities, Continuing -$262.00K
    Net Cash Flow From Financing Activities $7.57M
    Net Cash Flow From Financing Activities, Continuing $7.57M
    Net Cash Flow -$9.09M
    Net Cash Flow, Continuing -$9.09M
    Comprehensive Income/Loss -$18.65M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$18.65M
    Other Comprehensive Income/Loss $0.00